AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2642-9756/085
1 Obstetrics and Gynecology Department, Faculty of Medicine, Ain Shams University
*Corresponding Author: Nourhan Adel Abu Elfotouh Tantawy, Obstetrics and Gynecology Department, Faculty of Medicine, Ain Shams University
Citation: Mahmoud Youssef Ali Ahmed Abdalla, Abdel Rahman Mohammed Saleh & Nourhan Adel Abu Elfotouh Tantawy. (2021) Clomiphene Citrate versus Letrozole for Induction of Ovulation in Infertile women having Polycystic Ovarian Syndrome (Randomized Controlled Trial). J. Women Health Care and Issues. 4(7); DOI:10.31579/2642-9756/085
Copyright: © 2021 Nourhan Adel Abu Elfotouh Tantawy, This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received: 04 August 2021 | Accepted: 20 August 2021 | Published: 25 August 2021
Keywords:
Background: Polycystic ovary syndrome is a disorder but with unclear etiology that its diagnosis depends on exclusion of other etiologies with ovulatory disorders and androgen excess as congenital adrenal hyperplasia, 21-hydroxylase deficient non classic congenital adrenal hyperplasia (NCAH), adrenal or ovarian androgen-secreting tumors, disorders of adrenocortical dysfunction as Cushing’s disease, and abuse of androgenic or anabolic drugs. Polycystic ovary syndrome affects approximately 6-15% of women in reproductive age and constitutes 50% of the causes of infertility in women.
Aim of the Work: To compare the efficacy of letrozole on ovulation induction to that of clomiphene citrate in women suffering polycystic ovary syndrome and the effect on the follicular maturation, endometrial thickness and pregnancy rate. This study was carried in the outpatient infertility clinic of Ain-Shams Maternity Hospital during the period from November 2020 till April 2021.
Patients and Methods: This study included 80 infertile women diagnosed as having polycystic ovary syndrome. Women were randomized into two groups. Letrozole group (1) included 40 women who were given the aromatase inhibitor (Letrozole) orally in a 5mg dose daily from day 3 to day 7 of the menstrual cycle. While Clomiphene citrate group (2) included 40 women who were given the clomiphene citrate orally in 100mg dose daily from day 3 to day 7 of the menstrual cycle. All women were counseled and informed consent was obtained before recruitment.
Results: In this study, ovulation rate was significantly more frequent in the Letrozole group (82.5%, 33 women reached ovulation successfully) than in Clomiphene citrate group (60%, 24 women reached ovulation successfully) within P value=0.024. Clomiphene citrate at a dose of 100mg showed more efficacies in the number of follicle ≥18mm than Letrozole at a dose of 5mg. In Letrozole group, the number of follicles (≥18mm in diameter) ranged from 1 to 2 with a Mean±SD= 1.4±0.65 and in Clomiphene citrate group, the number of follicles (≥18mm in diameter) ranged from 1 to 3 with a Mean±SD= 1.9± 0.41 (P value=0.0001).
Conclusion: Letrozole can be considered as a first line treatment of anovulation in polycystic ovary syndrome. But, moreover studies including larger number of cases will further confirm the efficacy of letrozole versus clomiphene citrate in induction of ovulation, reaching to the optimum doses for aromatases inhibitors, more observation on endometrial thickness, incidence of pregnancy outcomes, incidence of abortion and incidence of congenital fetal malformations.
Ovulation is a main event in reproduction cycle. Anovulatory dysfunction is common problem and is responsible for approximately 40% of female infertility (Baadwy et al., 2009).
Polycystic ovary syndrome (PCOS) considers a complex condition characterized by elevated androgen levels, menstrual irregularities, and/or small cysts on one or both ovaries (Ndefo, 2013).
The National Institute of Child Health and Human Development (NICHD) of the National Institutes of Health (NIH) gathered a panel of experts who developed the first known criteria for PCOS in year 1991 and realized that ovarian morphology was a key component in the diagnosis. After that, The European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) sponsored a workshop in Rotterdam. Through the workshop, polycystic ovarian morphology on pelvic ultrasound was added to the NICHD/NIH criteria (Legro, 2013).
In year 2006, the Androgen Excess Society (AES) suggested that the NICHD/NIHS criteria might be used with modifications that contained the Rotterdam tool. The AES describes PCOS as a disorder primarily involving androgen excess, along with different combinations of phenotypic features (e.g., hyperandrogenemia, hirsutism, oligo-ovulation/anovulation, and/or polycystic ovaries) that may promote a more accurate diagnosis (Dewailly, 2011).
Using the modified Rotterdam criteria in clinical diagnosis of polycystic ovarian syndrome is easily reached and most often treatment can be initiated following a few basic investigation and exclusion of the male factor problem (Azziz, 2007).
For more than four decades, clomiphene citrate has been used as the first line therapy for induction of ovulation in women with anovulatory infertility and for super-ovulation in couples with unexplained infertility. It’s orally administrated, available and inexpensive (Palomba, 2004).
In addition, predictors of the ovulatory response to clomiphene are body mass index, the free androgen index, ovarian volume and low concentrations of IGF-BP-I. On the other hand, pregnancy predictors with clomiphene are age and the severity of the cycle disorders, i.e. better responses occur in women of a younger age and with maintained oligomenorrhoea or amenorrhea, suggesting that FSH threshold (amount of FSH required to stimulate the follicular maturation and the ensuing ovulation) and oocyte quality are specifically regulated (Imani et al., 1999).
Because of its long half-life (two weeks), clomiphene citrate accumulates in the body and may have a negative effect on the quality and quantity of cervical mucus, endometrial development, which may cause implantation failure, luteal phase defect (LPD) and significant thinning of endometrium. Clomiphene citrate resistance together with side effects like multi-follicular development and cyst formation are areas of concern. The desire for an effective alternative persist (Kamath, 2010).
Clomiphene Citrate has drawbacks, including its overall poor efficacy, a nearly high multiple-pregnancy rate (3 to 8%) as compared with the rate associated with unassisted conception (<1>
Letrozole is a third generation selective aromatase inhibitor that was used as an ovulation inductor in anovulatory infertility women with more than 5mm endometrial thickness (Guang and Rezk, 2018).
Letrozole has been in use as an ovulation induction agent for more than a decade. Even though emerging evidence suggests that it's an effective ovulation induction agent, comparable if not better than clomiphene (Kamath & George, 2011).
Other studies also reported that letrozole is effective in clomiphene-resistant patients, and also resulted in ovulation of 62
Table 1: Comparison between Letrozole Group and Clomiphene Citrate Group according to their demographic data regarding age (years), type of infertility, duration of infertility (years) and BMI [Weight/Height2].
t-Independent Sample t-test; z-Mann-Whitney test; x2: Chi-square test
p-value>0.05 NS; *p-value <0>
The two groups were comparable in age with the mean Age ±SD in each of Letrozole Group and Clomiphene Citrate Group was 27.33±2.78 compared to 28.20±3.66 respectively, there is no statistically significant difference between the two groups with p-value (p=0.232).
This table showed also Primary infertility that were comparable in each of Letrozole Group (were 33 patients (82.5%)) and Clomiphene Citrate Group (were 31 patients (77.5%)). there is no statistically significant difference between the two groups with p-value (p=0.567).
Also, the two groups were comparable in duration of infertility “years” with the mean in each of Letrozole Group and Clomiphene Citrate Group was 2.90±1.42 compared to 3.15±1.55 respectively, there is no statistically significant difference between the two groups with p-value (p=0.455).
Finally, the two groups were comparable in BMI with the mean in each of Letrozole Group and Clomiphene Citrate Group was 27.36±2.33 compared to 25.79±2.73 respectively, there is no statistically significant difference between the two groups with p-value (p=0.706).
Table 2: Comparison between Letrozole Group and Clomiphene Citrate Group according to their hormonal profile regarding FSH, LH and FSH/LH ratio.t-Independent Sample t-test; p-value>0.05 NS
The two groups were comparable in FSH with the mean ±SD in each of Letrozole Group and Clomiphene Citrate Group was 6.78±1.09 compared to 8.15±9.60 respectively, there is no statistically significant difference between the two groups with p-value (p=0.371).
This table shows also, the two groups were comparable in LH with the mean ±SD in each of Letrozole Group and Clomiphene Citrate Group was 14.90±1.57 compared to 14.85±2.13 respectively, there is no statistically significant difference between the two groups with p-value (p=0.910).
While, the two groups were comparable in FSH/LH ratio with the mean ±SD in each of Letrozole Group and Clomiphene Citrate Group was 2.33±0.45 compared to 2.35±0.42 respectively, there is no statistically significant difference between the two groups with p-value (p=0.857).
Table 3: Comparison between Letrozole Group and Clomiphene Citrate Group according to number of women had follicles ≥18mm and <12mm>
x2: Chi-square test; t-Independent Sample t-test; * p-value<0>
There was a highly statistically significant difference between two groups according to Number of women who had follicles ≥18mm and women who had follicles <12mm xss=removed>
There was a highly statistically significant difference between two groups according to Number of follicles ≥18mm on the day of hCG administration (p=0.0001). The highest value was found in Clomiphene citrate Group with Mean±SD 2.5 ±0.5 compared to Letrozole Group with Mean±SD 1.6± 0.7.
Also, there was a highly statistically significant difference between both group according to Diameter of the dominant follicle (p=0.0001). The highest value was found in Letrozole Group with Mean±SD 22.4 ± 1.32 compared to Clomiphene Citrate Group with Mean±SD 20.2± 1.15.
There was a highly statistically significant difference between two groups according to Number of women who received HCG (p= 0.034). The highest response was found in Letrozole Group 36 (95%) than Clomiphene Citrate Group 24 (80%).
There was a highly statistically significant difference between two groups according to Endometrial thickness (mm) on the day of hCG administration (p=0.0001). The highest value was found in Letrozole Group 8.5±0.5 compared to Clomiphene Citrate Group 7.5±1.26.
There was a highly statistically significant difference between two groups according to Mid-luteal phase serum progesterone level (p=0.0001). The highest value was found in Letrozole Group 14.12±1.71 ng/mL compared to Clomiphene Citrate Group 11.27±1.6 ng/mL.
There was a highly statistically significant difference between two groups according to Estradiol serum level on the day of hCG administration (p=0.001). The highest value was found in Clomiphene Citrate Group 189.3±29.2 pg/mL compared to Letrozole Group 168.8± 21.3 pg/mL.
The two groups were comparable in Number of women became pregnant on the first cycle, in Letrozole Group 4 women became pregnant (10%) while in Clomiphene Citrate Group 1 became pregnant (3%), there is no statistically significant difference between the two groups with p-value (p=0.163).
Table 4: Comparison between Pregnant and non-pregnant women in Letrozole Group according to their number of follicle(s) ≥18mm on the day of hCG administration, diameter of the dominant follicle, endometrial thickness (mm), estradiol serum level on the day of hCG administration (pg/ml) and mid-luteal phase serum progesterone level (ng/mL)
t-Independent Sample t-test; *p-value<0>
There was a highly statistically significant difference between two groups according to Number of follicles ≥18mm on the day of hCG administration (p=0.0001). The highest value was found in Pregnant Group with Mean±SD 2.03± 0.5 compared to Non-pregnant Group with Mean±SD 1±0.6.
Also, there was a highly statistically significant difference between both group according to Diameter of the dominant follicle (p=0.0001). The highest value was found in Pregnant Group with Mean±SD 23.4± 0.9 compared to Non-pregnant Group with Mean±SD 17.3± 1.47.
There was a highly statistically significant difference between two groups according to Endometrial thickness (mm) on the day of hCG administration (p=0.0001). The highest value was found in Pregnant Group 8.85± 0.6 compared to Non-pregnant Group 6.6±0.3.
There was a highly statistically significant difference between two groups according to Mid-luteal phase serum progesterone level (p=0.0001). The highest value was found in Pregnant Group 14.5±0.6 ng/mL compared to Non-pregnant Group 9.2±1.6 ng/mL.
There was a highly statistically significant difference between two groups according to Estradiol serum level on the day of hCG administration (p=0.0001). The highest value was found in Pregnant Group 167.3±13.6 pg/mL compared to Non-pregnant 100.1±17.8 pg/mL.
Polycystic ovary syndrome (PCO) is a disorder but with unclear etiology. For that, it became a diagnosis of exclusion, by exclusion of other etiologies with androgen excess and ovulatory disorders. For example, Androgen excess disorders should be excluded are 21-hydroxylase deficient non classic congenital adrenal hyperplasia (NCAH), adrenal or ovarian androgen-secreting tumors, disorders of adrenocortical dysfunction as Cushing’s disease, and abuse of androgenic or anabolic drugs. Although not true androgen excess, namely idiopathic hirsutism, should be excluded (Azziz, 2007).
According to Rotterdam criteria, diagnosis of polycystic ovary syndrome needs two of three characteristics: oligomenorrhea and/or anovulation, clinical and/or biochemical signs of hyperandrogenism and polycystic ovaries according to pelvic ultrasound (Dunaif, 2013; Lawrenson, 2014; Escobar-Morreale, 2018).
Clomiphene citrate is a non-steroidal selective estrogen-receptor modulator that binds to estrogen receptors and makes agonist effects in some tissues and antagonist effect on other tissue (Grese, 1997; Barroso, 2006).
The main mechanism of action of clomiphene citrate is to induce ovarian stimulation through the anti-estrogenic effect on the hypothalamus and pituitary leading to increase the pulse frequency and concentration of the FSH and LH within increase of ovarian follicles to reach the ovulation (Casper & Mitwally, 2006; Porter, 2008).
Aromatase inhibitors are three generations that might be steroidal or non-steroidal inhibitors (Bhatnagar, 1990 and Brodie, 1996) which block estrogen synthesis affect directly hypothalamic pituitary ovarian axis function and that theoretically may increase pregnancy rate (Casper & Mitwally, 2006).
Letrozole is a triazole derivative (antifungal) which is potent, reversible, competitive, non-steroidal, and highly selective aromatase inhibitor (Badawy, 2009). It prevents androgen to estrogen conversion in the ovary and leads to decrease in estrogen level providing negative feedback in hypothalamus which stimulates the pituitary gland to secrete FSH and development of follicle (Stafeno, Legro et al., 2014). Letrozole is rapidly absorbed from GIT and completely bioavailable up to 99.9
Letrozole has efficacy as that of clomiphene citrate in induction of ovulation in polycystic ovary syndrome. Within 5mg daily dose of letrozole, women can achieve ovulation in about (82.5%) and pregnancy in about (37.5%).
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
